{
    "sec_cik": "0000014272",
    "sec_company_name": "BRISTOL MYERS SQUIBB CO (Filer)",
    "document_type": "EX991",
    "sec_form_header": "Form 8-K",
    "sec_period_of_report": "20160112",
    "sec_filing_date": "20160112",
    "sec_changed_date": "20160112",
    "sec_accepted_date": "20160112122110",
    "sec_index_url": "https://www.sec.gov//Archives/edgar/data/14272/000156761916001658/0001567619-16-001658-index.htm",
    "sec_url": "https://www.sec.gov//Archives/edgar/data/14272/000156761916001658/0001567619-16-001658.txt",
    "metadata_file_name": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0005\005\BMY_0000014272_EX991_20160112_EX-99_metadata.json",
    "original_file_name": "",
    "original_file_size": "1942 chars",
    "document_group": "EX-99",
    "section_name": "EX-99",
    "section_n_characters": 477,
    "endpoints": [
        "Exhibit 99.1 ",
        " 2015: Leading in Immuno-Oncology Strong US commercial execution 1 Total IO Market â€“ Weekly IMS DDD + Xponent Yervoy Opdivo BMS I-OPortfolio Keytruda Note: This information is an estimate derived from the use of information under license from the following IMS Health information services: Xponent & DDD weekly dollars, for the period of 1/2/2015 through 12/31/2015. IMS expressly reserves all rights, including rights of copying, distribution and republication."
    ],
    "extraction_method": "html",
    "warnings": [],
    "company_description": "BMY",
    "output_file": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0005\005\BMY_0000014272_EX991_20160112_EX-99_excerpt.txt",
    "time_elapsed": 0.0,
    "batch_number": 5,
    "batch_signature": "",
    "batch_start_time": "2023-04-16 21:41:24.213091",
    "batch_machine_id": "DESKTOP-BTCJU5K",
    "section_end_time": "2023-04-16 21:57:02.495034"
}